LTS completes its entry into large molecule drug delivery with the acquisition of the Sorrel wearable injection device business - PRN India News webindia123.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from webindia123.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ LTS LOHMANN Therapie-Systeme AG ("LTS"), a leading pharmaceutical technology company that develops and manufactures innovative drug delivery.
ANDERNACH, Germany, June 8, 2023 /PRNewswire/ LTS LOHMANN Therapie-Systeme AG ("LTS"), a leading pharmaceutical technology company that develops and manufactures innovative drug delivery
LTS completes its entry into large molecule drug delivery with the acquisition of the Sorrel wearable injection device business laragione.eu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from laragione.eu Daily Mail and Mail on Sunday newspapers.
LTS LOHMANN Therapie-Systeme (LTS), a leading pharmaceutical technology company that develops and manufactures innovative drug delivery systems such as Transdermal Patches (TTS), Oral Thin Films (OTF) and Micro